Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.58
0.38 (1.88%)
At close: Aug 15, 2025, 10:05 AM

Neurogene Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
136.59M 148.21M 82.02M 70.54M
Short-Term Investments
175.82M 48.95M 58.5M n/a
Long-Term Investments
n/a 508K 878K 878K
Other Long-Term Assets
1.31M 764K -791K -1.01M
Receivables
648K 600K 990K 790K
Inventory
n/a n/a 1.08M 1.91M
Other Current Assets
981K 1.09M -448K -1.2M
Total Current Assets
315.92M 200.35M 84.72M 73.96M
Property-Plant & Equipment
18.49M 20.95M 24.46M 27.53M
Goodwill & Intangibles
n/a n/a n/a 128K
Total Long-Term Assets
19.81M 22.23M 24.55M 27.53M
Total Assets
335.73M 222.57M 109.27M 101.49M
Account Payables
1.34M 2.6M 625K 5.63M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
3M n/a n/a 1.22M
Other Current Liabilities
1.43M 6.71M 167K 132K
Total Current Liabilities
15.16M 22.97M 6.65M 10.86M
Long-Term Debt
n/a n/a 244.37M n/a
Other Long-Term Liabilities
769K 1.21M n/a 177.91M
Total Long-Term Liabilities
10.2M 13.58M 248.35M 182.51M
Total Liabilities
25.36M 36.55M 255M 193.36M
Total Debt
12.43M 16.25M 4.69M 5.21M
Common Stock
n/a n/a 1K 1K
Retained Earnings
-262.3M -187.15M -150.84M -95.65M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
310.38M 186.02M -145.74M -91.88M
Total Investments
175.82M 49.45M 59.38M 878K